Transdermal Medical Patch Market Size Report | 2023-2028
[Research Report] The transdermal medical patch market is projected to reach US$ 10,799.74 million by 2028 from US$ 8,247.21 million in 2022. It is expected to register a CAGR of 4.0% from 2023 to 2028.
Analyst Perspective
The rising prevalence of chronic diseases and growing consumption of tobacco drive the transdermal medical patch market growth. The rising number of patients suffering from chronic conditions and increasing activities in research and development, are the key factors propelling the market for transdermal medical patches. Additionally, increasing activities in research and development, are expected to boost the transdermal medical patch market growth. Furthermore, the transdermal medical patch market key players are focusing on strategic initiatives by launching new products to expand their geographic reach and enhance capacities to cater to a large customer base. For instance, in March 2021, Hisamitsu Pharmaceutical Co., Inc. announced approval for the manufacturing and marketing of ZICTHORU Tapes 75 mg, transdermal, pain treatment NSAID patch for “cancer pain” in Japan. The product is a systemic transdermal formulation developed using Hisamitsu’s TDDS (Transdermal Drug Delivery System) technology. The product's efficacy and safety have been confirmed in clinical trials in patients with cancer pain.
Transdermal Medical Patch Market - Market Overview
A transdermal medical patch, also known as medicated patch or skin patch, is a type of medical device designed to deliver medications or other therapeutic substances through the skin and into the blood stream. These patches are typically thin, adhesive patches that applied directly to the skin allowing the medication to be absorbed gradually over a specified period. Transdermal patches provide a convenient method of medication administration. They can be applied to the skin and worn for a specified duration, often ranging for a few hours to several days, depending on the medication and desired therapeutic effect.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Transdermal Medical Patch Market: Strategic Insights
Market Size Value in US$ 8,247.21 million in 2022 Market Size Value by US$ 10,799.74 million by 2028 Growth rate CAGR of 4.0% from 2023 to 2028 Forecast Period 2023-2028 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Transdermal Medical Patch Market: Strategic Insights
| Market Size Value in | US$ 8,247.21 million in 2022 |
| Market Size Value by | US$ 10,799.74 million by 2028 |
| Growth rate | CAGR of 4.0% from 2023 to 2028 |
| Forecast Period | 2023-2028 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Driver
Increasing Prevalence of Chronic Diseases Drives Global Transdermal Medical Patch Market
According to the Centers for Disease Control and Prevention (CDC), chronic diseases such as heart disease, cancer, and diabetes account for a significant amount (US$ 4,100,000 million) in annual healthcare spending in the US. Transdermal medical patches are used to administer medications to people suffering from chronic diseases such as heart disease, stroke, diabetes, cancer, obesity, and arthritis. According to the World Health Organization (WHO), ~17.9 million people died from CVDs in 2019, representing 32% of all deaths recorded globally. 85% of CVD-related deaths were due to heart attacks. According to the same source, over three-quarters of CVD deaths occurred in low-and-middle-income countries in 2019, including 17 million premature deaths (under the age of 70) due to noncommunicable diseases; CVDs were a cause of death in 38% of the mortalities associated with noncommunicable diseases.
A cardiac patch provides an excellent platform for cell engraftment improvement. For example, a vascularized cardiac patch developed recently shows promising potential for treating ischemic heart injuries. Nitroglycerin transdermal patches are used to prevent angina (chest pain) episodes in people with coronary artery disease. It works by relaxing the blood vessels and reducing the stress on the heart, thereby lowering the need for oxygen. However, these patches cannot be used to treat angina attacks that have already begun.
Alzheimer's disease was officially listed as the sixth-leading cause of death in the US in 2019 and the seventh-leading cause of death in 2020 and 2021. According to the 2023 stats by the National Institute of Health, ~6.7 million Americans (i.e., 1 in 9 people or 10.8%), aged 65 and older, have Alzheimer's dementia. The percentage of people with Alzheimer's dementia increases with age. 5% of people aged 65–74, 13.1% aged 75–84, and 33.3% aged 85 and above have Alzheimer's dementia. According to a published the “Global Prevalence of Young-Onset Dementia" report published in 2021, the prevalence of younger-onset dementia in the US is estimated at 110 of every 100,000 people aged 30–64 years, or ~200,000 Americans in total. Thus, individuals with age less than 65 can also develop Alzheimer's dementia.
Rivastigmine patch is used to treat dementia (memory loss) associated with mild, moderate, or severe Alzheimer's disease or mild-to-moderate dementia associated with Parkinson's disease. Rivastigmine and donepezil, which are cholinesterase inhibitors, exhibit a dose–response relationship, with higher doses of the drugs demonstrating greater efficacy. As a small, lipophilic, and hydrophilic molecule, rivastigmine is chemically well-suited for transdermal delivery. The technology underlying the rivastigmine patch contributes to its discreetly small and thin appearance. Thus, the rivastigmine patch enables quick and easy access to high-dose efficacy.
Therefore, the increasing prevalence of chronic diseases catalyzes the demand for medical patches, thus surging transdermal medical patch market.
Transdermal Medical Patch Market - Segmental Analysis
Based on type, the transdermal medical patch market is segmented into single-layer drug in-adhesive, multi-layer drug in-adhesive, reservoir, vapor patch and matrix. The matrix segment held the largest market share in 2022, and the same segment is anticipated to register the highest CAGR of 5.3% during the forecast period. The market position of this segment is due to the patient compliance and convenience. The matrix patch is designed with features that further improve patient compliance, such as extended wear time, simplified application, or smart monitoring capabilities to track medication adherence. The matrix patch incorporates sensors or monitoring capabilities to provide real-time feedback on a patient’s health status.
Transdermal Medical Patch Market - Regional Analysis
Asia-Pacific is the dominating region in the transdermal medical patch market. The Asia-Pacific transdermal medical patch market was valued at US$ 2,024.32 million in 2022 and is projected to reach US$ 2,744.32 million by 2028; it is expected to grow at a CAGR of 5.2% during the forecast period. The Asia-Pacific transdermal medical patch market is segmented into China, the Japan, India, and the Rest of Asia-Pacific. The regional growth is attributed to growing research on cancer and gene mutations, increasing disease modeling, and developments by market players offering transdermal medical patch. Factors such as developing healthcare facilities, growing aging population to share key facts associated with stem cell technologies and increasing partnerships with foreign entities are likely to further propel the transdermal medical patch market growth during the forecast period.
Transdermal Medical Patch Market - Key Player Analysis
The transdermal medical patch market analysis consists of the players such as Hisamitsu Pharmaceutical Co Inc, Medline Industries LP, Johnson & Johnson, Novartis AG, Teva Pharmaceutical Industries Ltd, UCB SA, Viatris Inc, Endo Pharmaceuticals Inc, Boehringer Ingelheim International GmbH, and Corium, LLC. Among the players in the transdermal medical patch market Hisamitsu Pharmaceutical Co Inc and Novartis AG are the top two players owing to the diversified product portfolio offered.
Transdermal Medical Patch Market Report Scope
Transdermal Medical Patch Market - Recent Developments
Inorganic and organic strategies such as mergers and acquisitions are highly adopted by companies in the transdermal medical patch market. A few recent key market developments are listed below:
- In 2019, Nitto Denko Corporation announced the Bisono Tape 2mg, transdermal patches containing a β1 blocker that was co-developed with Toa Eiyo Ltd., launched by Toa Eiyo and Astellas Pharma Inc.
- In June 2022, Hisamitsu Pharmaceutical Co., Inc. has been approved for the additional indications of “low back pain, humeroscapular periarthritis, cervico-omo-brachial syndrome and tenosynovitis” for ZICTHORU Tapes, transdermal, pain treatment NSAID patch in Japan. The product was approved for manufacturing and marketing approval for “analgesia in various cancer” in March 2021. This approval is based on the data of Phase III clinical studies that evaluated the efficacy and safety of the product in patients with low back pain, humeroscapular periarthritis, cervico-omo-brachial syndrome and tenosynovitis. With this approval of the additional indications, Hisamitsu expects the product to be a new option for the treatment of low back pain, humeroscapular periarthritis, cervico-omo-brachial syndrome and tenosynovitis.
- In January 2021, Hisamitsu Pharmaceutical Co., Inc. has commenced the Phase III clinical study in the U.S. for transdermal, pain relief and anti-inflammatory patch for the treatment of Osteoarthritis knee pain. The clinical study will be conducted by the U.S. subsidiary, Noven Pharmaceuticals, Inc. The investigational product is a transdermal formulation developed using Hisamitsu’s TDDS (Transdermal Drug Delivery System) technology. Hisamitsu Pharmaceutical hopes the investigational product will be a new treatment option for Osteoarthritis of the knee, demonstrating efficacy and safety by achieving higher drug delivery to the affected area as one of the transdermal formulation attributes.
- In September 2022, Corium, Inc launched ADLARITY (donepezil transdermal system) and is now available for prescription in the U.S. for treating patients with mild, moderate, or severe dementia of Alzheimer's type.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Application, and Distribution Channel
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The matrix segment held the largest share of the market in 2022. Also, the same segment is estimated to register the highest CAGR in the market during the forecast period.
The CAGR value of the transdermal medical patch market during the forecasted period of 2023-2028 is 4.0%.
The factors that are driving the growth of the transdermal medical patch market are the increasing aging population, increasing prevalence of chronic diseases and growing consumption of tobacco and increasing partnerships with foreign entities. These are some of the major factors contributing to the growth of the transdermal medical patch industry.
The Asia Pacific is expected to be the fastest-growing region in the transdermal medical patch market over the forecast period due to the increasing prevalence of chronic diseases and the growing research on cancer and gene mutations, increasing disease modeling, and developments by market players offering transdermal medical patch.
The transdermal medical patch market is expected to be valued at US$ 10,799.74 million in 2028.
The transdermal medical patch market majorly consists of the players, such as Hisamitsu Pharmaceutical Co Inc, Medline Industries LP, Johnson & Johnson, Novartis AG, Teva Pharmaceutical Industries Ltd, UCB SA, Viatris Inc, Endo Pharmaceuticals Inc, Boehringer Ingelheim International GmbH, and Corium, LLC.
The transdermal medical patch is a medicated patch that can deliver drugs through skin portals directly to the bloodstream at a predetermined rate. This is the most comfortable dosage form – it is non-invasive, avoids the gastrointestinal tract and bypasses first-pass metabolism, can have multiday therapy, and can be terminated at any time.
The transdermal medical patch market is estimated to be valued at US$ 8,247.21 million in 2022.
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Transdermal Medical Patch Market – by Type
1.3.2 Global Transdermal Medical Patch Market – by Application
1.3.3 Global Transdermal Medical Patch Market – by Distribution Channel
1.3.4 Global Transdermal Medical Patch Market – by Geography
2. Transdermal Medical Patch Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Transdermal Medical Patch Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East & Africa PEST Analysis
4.2.5 South & Central America PEST Analysis
4.3 Expert’s Opinion
5. Transdermal Medical Patch Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Growing Consumption of Tobacco
5.2 Market Restraints
5.2.1 Recalls of Transdermal Medical Patches due to Drug Failure
5.3 Market Opportunities
5.3.1 Increasing Strategic Initiatives
5.4 Future Trends
5.4.1 Advancements in Smart Patches and Three-Dimensional (3D)-Printed Patches
5.5 Impact analysis
6. Transdermal Medical Patch Market – Global Analysis
6.1 Global Transdermal Medical Patch Market Revenue Forecast and Analysis
6.2 Global Transdermal Medical Patch Market, by Geography – Forecast and Analysis
6.3 Market Positioning of Key Players
7. Global Transdermal Medical Patch Market – Revenue and Forecast to 2028 – By Type
7.1 Overview
7.2 Transdermal Medical Patch Market Revenue Share, by Type (2022 and 2028)
7.3 Single-Layer Drug In-Adhesive
7.3.1 Overview
7.3.2 Single-Layer Drug In-Adhesive: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Multi-Layer Drug In-Adhesive
7.4.1 Overview
7.4.2 Multi-Layer Drug In-Adhesive: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Reservoir
7.5.1 Overview
7.5.2 Reservoir: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Vapor Patch
7.6.1 Overview
7.6.2 Vapor Patch: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Matrix
7.7.1 Overview
7.7.2 Matrix: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
8. Global Transdermal Medical Patch Market – Revenue and Forecast to 2028 – By Application
8.1 Overview
8.2 Transdermal Medical Patch Market Revenue Share, by Application (2022 and 2028)
8.3 Neurologic Conditions
8.3.1 Overview
8.3.2 Neurologic Conditions: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Pain Management
8.4.1 Overview
8.4.2 Pain Management: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Nicotine Cessation
8.5.1 Overview
8.5.2 Nicotine Cessation: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Cardiovascular Disorders
8.6.1 Overview
8.6.2 Cardiovascular Disorders: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Hormonal Therapy
8.7.1 Overview
8.7.2 Hormonal Therapy: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
9. Global Transdermal Medical Patch Market – Revenue and Forecast to 2028 – By Distribution Channels
9.1 Overview
9.2 Transdermal Medical Patch Market Revenue Share, by Distribution Channels (2022and 2028)
9.3 Hospital Pharmacies
9.3.1 Overview
9.3.2 Hospital Pharmacies: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Retail Pharmacies
9.4.1 Overview
9.4.2 Retail Pharmacies: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Online Pharmacies
9.5.1 Overview
9.5.2 Online Pharmacies: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10. Transdermal Medical Patch Market – Revenue and Forecast to 2028 – Geographic Analysis
10.1 North America: Transdermal Medical Patch Market
10.1.1 The Overview
10.1.2 North America: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3 North America: Transdermal Medical Patch Market, by Type, 2020–2028 (US$ Million)
10.1.4 North America: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
10.1.5 North America: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
10.1.6 North America: Transdermal Medical Patch Market, by Country, 2022 & 2028 (%)
10.1.6.1 US: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.1 Overview
10.1.6.1.2 US: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.3 US: Transdermal Medical Patch Market, by Type, 2020–2028 (US$ Million)
10.1.6.1.4 US: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
10.1.6.1.5 US: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
10.1.6.2 Canada: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.1 Overview
10.1.6.2.2 Canada: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.3 Canada: Transdermal Medical Patch Market, by Type, 2020–2028 (US$ Million)
10.1.6.2.4 Canada: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
10.1.6.2.5 Canada: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
10.1.6.3 Mexico: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.1 Overview
10.1.6.3.2 Mexico: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.3 Mexico: Transdermal Medical Patch Market, by Type, 2020–2028 (US$ Million)
10.1.6.3.4 Mexico: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
10.1.6.3.5 Mexico: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
10.2 Europe: Transdermal Medical Patch Market
10.2.1 Overview
10.2.2 Europe: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.2.3 Europe: Transdermal Medical Patch Market, by Type, 2020–2028 (US$ Million)
10.2.4 Europe: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
10.2.5 Europe: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
10.2.6 Europe: Transdermal Medical Patch Market, by Country, 2022 & 2028 (%)
10.2.6.1 UK: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.1 Overview
10.2.6.1.2 UK: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.3 UK: Transdermal Medical Patch Market, by Type, 2020–2028 (US$ Million)
10.2.6.1.4 UK: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
10.2.6.1.5 UK: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
10.2.6.2 Germany: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.1 Overview
10.2.6.2.2 Germany: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.3 Germany: Transdermal Medical Patch Market, by Type, 2020–2028 (US$ Million)
10.2.6.2.4 Germany: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
10.2.6.2.5 Germany: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
10.2.6.3 France: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.1 Overview
10.2.6.3.2 France: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.3 France: Transdermal Medical Patch Market, by Type, 2020–2028 (US$ Million)
10.2.6.3.4 France: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
10.2.6.3.5 France: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
10.2.6.4 Spain: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.1 Overview
10.2.6.4.2 Spain: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.3 Spain: Transdermal Medical Patch Market, by Type, 2020–2028 (US$ Million)
10.2.6.4.4 Spain: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
10.2.6.4.5 Spain: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
10.2.6.5 Italy: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.1 Overview
10.2.6.5.2 Italy: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.3 Italy: Transdermal Medical Patch Market, by Type, 2020–2028 (US$ Million)
10.2.6.5.4 Italy: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
10.2.6.5.5 Italy: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
10.2.6.6 Rest of Europe: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.1 Overview
10.2.6.6.2 Rest of Europe: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.3 Rest of Europe: Transdermal Medical Patch Market, by Type, 2020–2028 (US$ Million)
10.2.6.6.4 Rest of Europe: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
10.2.6.6.5 Rest of Europe: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
10.3 Asia-Pacific: Transdermal Medical Patch Market
10.3.1 Overview
10.3.2 Asia-Pacific: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.3.3 Asia-Pacific: Transdermal Medical Patch Market, by Type, 2020–2028 (US$ Million)
10.3.4 Asia-Pacific: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
10.3.5 Asia-Pacific: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
10.3.6 Asia-Pacific: Transdermal Medical Patch Market, by Country, 2022 & 2028 (%)
10.3.6.1 China: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.1 Overview
10.3.6.1.2 China: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.3 China: Transdermal Medical Patch Market, by Type, 2020–2028 (US$ Million)
10.3.6.1.4 China: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
10.3.6.1.5 China: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
10.3.6.2 Japan: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.1 Overview
10.3.6.2.2 Japan: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.3 Japan: Transdermal Medical Patch Market, by Type, 2020–2028 (US$ Million)
10.3.6.2.4 Japan: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
10.3.6.2.5 Japan: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
10.3.6.3 India: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.1 Overview
10.3.6.3.2 India: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.3 India: Transdermal Medical Patch Market, by Type, 2020–2028 (US$ Million)
10.3.6.3.4 India: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
10.3.6.3.5 India: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
10.3.6.4 South Korea: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.1 Overview
10.3.6.4.2 South Korea: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.3 South Korea: Transdermal Medical Patch Market, by Type, 2020–2028 (US$ Million)
10.3.6.4.4 South Korea: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
10.3.6.4.5 South Korea: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
10.3.6.5 Australia: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.1 Overview
10.3.6.5.2 Australia: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.3 Australia: Transdermal Medical Patch Market, by Type, 2020–2028 (US$ Million)
10.3.6.5.4 Australia: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
10.3.6.5.5 Australia: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
10.3.6.6 Rest of Asia-Pacific: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.1 Overview
10.3.6.6.2 Rest of Asia-Pacific: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.3 Rest of Asia-Pacific: Transdermal Medical Patch Market, by Type, 2020–2028 (US$ Million)
10.3.6.6.4 Rest of Asia-Pacific: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
10.3.6.6.5 Rest of Asia-Pacific: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
10.4 Middle East & Africa: Transdermal Medical Patch Market
10.4.1 The Overview
10.4.2 Middle East & Africa: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.4.3 Middle East & Africa: Transdermal Medical Patch Market, by Type, 2020–2028 (US$ Million)
10.4.4 Middle East & Africa: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
10.4.5 Middle East & Africa: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
10.4.6 Middle East & Africa: Transdermal Medical Patch Market, by Country, 2022 & 2028 (%)
10.4.6.1 Saudi Arabia: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.1 Overview
10.4.6.1.2 Saudi Arabia: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.3 Saudi Arabia: Transdermal Medical Patch Market, by Type, 2020–2028 (US$ Million)
10.4.6.1.4 Saudi Arabia: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
10.4.6.1.5 Saudi Arabia: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
10.4.6.2 UAE: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.1 Overview
10.4.6.2.2 UAE: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.3 UAE: Transdermal Medical Patch Market, by Type, 2020–2028 (US$ Million)
10.4.6.2.4 UAE: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
10.4.6.2.5 UAE: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
10.4.6.3 South Africa: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.1 Overview
10.4.6.3.2 South Africa: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.3 South Africa: Transdermal Medical Patch Market, by Type, 2020–2028 (US$ Million)
10.4.6.3.4 South Africa: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
10.4.6.3.5 South Africa: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
10.4.6.4 Rest of Middle East & Africa: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.1 Overview
10.4.6.4.2 Rest of Middle East & Africa: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.3 Rest of Middle East & Africa: Transdermal Medical Patch Market, by Type, 2020–2028 (US$ Million)
10.4.6.4.4 Rest of Middle East & Africa: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
10.4.6.4.5 Rest of Middle East & Africa: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
10.5 South & Central America: Transdermal Medical Patch Market
10.5.1 Overview
10.5.2 South & Central America: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.5.3 South & Central America: Transdermal Medical Patch Market, by Type, 2020–2028 (US$ Million)
10.5.4 South & Central America: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
10.5.5 South & Central America: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
10.5.6 South & Central America: Transdermal Medical Patch Market, by Country, 2022 & 2028 (%)
10.5.6.1 Brazil: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.1 Overview
10.5.6.1.2 Brazil: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.3 Brazil: Transdermal Medical Patch Market, by Type, 2020–2028 (US$ Million)
10.5.6.1.4 Brazil: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
10.5.6.1.5 Brazil: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
10.5.6.2 Argentina: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.1 Overview
10.5.6.2.2 Argentina: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.3 Argentina: Transdermal Medical Patch Market, by Type, 2020–2028 (US$ Million)
10.5.6.2.4 Argentina: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
10.5.6.2.5 Argentina: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
10.5.6.3 Rest of South & Central America: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.1 Overview
10.5.6.3.2 Rest of South & Central America: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.3 Rest of South & Central America: Transdermal Medical Patch Market, by Type, 2020–2028 (US$ Million)
10.5.6.3.4 Rest of South & Central America: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
10.5.6.3.5 Rest of South & Central America: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
11. Impact Of COVID-19 Pandemic on Transdermal Medical Patch Market
11.1 North America: Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
11.5 South & Central America: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies
12.2.1 Overview
13. Company Profiles
13.1 Hisamitsu Pharmaceutical Co Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Medline Industries LP
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Johnson & Johnson
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Novartis AG
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Teva Pharmaceutical Industries Ltd
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 UCB SA
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Viatris Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Endo Pharmaceuticals Inc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Boehringer Ingelheim International GmbH
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Corium, LLC.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Transdermal Medical Patch Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Transdermal Medical Patch Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Transdermal Medical Patch Market, by Distribution Channels – Revenue and Forecast to 2028 (US$ Million)
Table 4. US Transdermal Medical Patch Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 5. US Transdermal Medical Patch Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 6. US Transdermal Medical Patch Market, by Distribution Channels – Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada Transdermal Medical Patch Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada Transdermal Medical Patch Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Transdermal Medical Patch Market, by Distribution Channels – Revenue and Forecast to 2028 (US$ Million)
Table 10. Mexico Transdermal Medical Patch Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 11. Mexico Transdermal Medical Patch Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico Transdermal Medical Patch Market, by Distribution Channels – Revenue and Forecast to 2028 (US$ Million)
Table 13. Europe Transdermal Medical Patch Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. Europe Transdermal Medical Patch Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 15. Europe Transdermal Medical Patch Market, by Distribution Channels – Revenue and Forecast to 2028 (US$ Million)
Table 16. UK Transdermal Medical Patch Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 17. UK Transdermal Medical Patch Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 18. UK Transdermal Medical Patch Market, by Distribution Channels – Revenue and Forecast to 2028 (US$ Million)
Table 19. Germany Transdermal Medical Patch Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 20. Germany Transdermal Medical Patch Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 21. Germany Transdermal Medical Patch Market, by Distribution Channels – Revenue and Forecast to 2028 (US$ Million)
Table 22. France Transdermal Medical Patch Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 23. France Transdermal Medical Patch Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 24. France Transdermal Medical Patch Market, by Distribution Channels – Revenue and Forecast to 2028 (US$ Million)
Table 25. Spain Transdermal Medical Patch Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 26. Spain Transdermal Medical Patch Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 27. Spain Transdermal Medical Patch Market, by Distribution Channels – Revenue and Forecast to 2028 (US$ Million)
Table 28. Italy Transdermal Medical Patch Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 29. Italy Transdermal Medical Patch Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 30. Italy Transdermal Medical Patch Market, by Distribution Channels – Revenue and Forecast to 2028 (US$ Million)
Table 31. Rest of Europe Transdermal Medical Patch Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 32. Rest of Europe Transdermal Medical Patch Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 33. Rest of Europe Transdermal Medical Patch Market, by Distribution Channels – Revenue and Forecast to 2028 (US$ Million)
Table 34. Asia-Pacific Transdermal Medical Patch Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 35. Asia-Pacific Transdermal Medical Patch Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 36. Asia-Pacific Transdermal Medical Patch Market, by Distribution Channels – Revenue and Forecast to 2028 (US$ Million)
Table 37. China Transdermal Medical Patch Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 38. China Transdermal Medical Patch Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 39. China Transdermal Medical Patch Market, by Distribution Channels – Revenue and Forecast to 2028 (US$ Million)
Table 40. Japan Transdermal Medical Patch Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 41. Japan Transdermal Medical Patch Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 42. Japan Transdermal Medical Patch Market, by Distribution Channels – Revenue and Forecast to 2028 (US$ Million)
Table 43. India Transdermal Medical Patch Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 44. India Transdermal Medical Patch Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 45. India Transdermal Medical Patch Market, by Distribution Channels – Revenue and Forecast to 2028 (US$ Million)
Table 46. South Korea Transdermal Medical Patch Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 47. South Korea Transdermal Medical Patch Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 48. South Korea Transdermal Medical Patch Market, by Distribution Channels – Revenue and Forecast to 2028 (US$ Million)
Table 49. Australia Transdermal Medical Patch Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 50. Australia Transdermal Medical Patch Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 51. Australia Transdermal Medical Patch Market, by Distribution Channels – Revenue and Forecast to 2028 (US$ Million)
Table 52. Rest of Asia-Pacific Transdermal Medical Patch Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 53. Rest of Asia-Pacific Transdermal Medical Patch Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 54. Rest of Asia-Pacific Transdermal Medical Patch Market, by Distribution Channels – Revenue and Forecast to 2028 (US$ Million)
Table 55. Middle East & Africa Transdermal Medical Patch Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 56. Middle East & Africa Transdermal Medical Patch Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 57. Middle East & Africa Transdermal Medical Patch Market, by Distribution Channels – Revenue and Forecast to 2028 (US$ Million)
Table 58. Saudi Arabia Transdermal Medical Patch Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 59. Saudi Arabia Transdermal Medical Patch Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 60. Saudi Arabia Transdermal Medical Patch Market, by Distribution Channels – Revenue and Forecast to 2028 (US$ Million)
Table 61. UAE Transdermal Medical Patch Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 62. UAE Transdermal Medical Patch Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 63. UAE Transdermal Medical Patch Market, by Distribution Channels – Revenue and Forecast to 2028 (US$ Million)
Table 64. South Africa Transdermal Medical Patch Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 65. South Africa Transdermal Medical Patch Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 66. South Africa Transdermal Medical Patch Market, by Distribution Channels – Revenue and Forecast to 2028 (US$ Million)
Table 67. Rest of Middle East & Africa Transdermal Medical Patch Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 68. Rest of Middle East & Africa Transdermal Medical Patch Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 69. Rest of Middle East & Africa Transdermal Medical Patch Market, by Distribution Channels – Revenue and Forecast to 2028 (US$ Million)
Table 70. South & Central America Transdermal Medical Patch Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 71. South & Central America Transdermal Medical Patch Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 72. South & Central America Transdermal Medical Patch Market, by Distribution Channels – Revenue and Forecast to 2028 (US$ Million)
Table 73. Brazil Transdermal Medical Patch Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 74. Brazil Transdermal Medical Patch Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 75. Brazil Transdermal Medical Patch Market, by Distribution Channels – Revenue and Forecast to 2028 (US$ Million)
Table 76. Argentina Transdermal Medical Patch Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 77. Argentina Transdermal Medical Patch Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 78. Argentina Transdermal Medical Patch Market, by Distribution Channels – Revenue and Forecast to 2028 (US$ Million)
Table 79. Rest of South & Central America Transdermal Medical Patch Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 80. Rest of South & Central America Transdermal Medical Patch Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 81. Rest of South & Central America Transdermal Medical Patch Market, by Distribution Channels – Revenue and Forecast to 2028 (US$ Million)
Table 82. Recent Growth Strategies in Transdermal Medical Patch Market
Table 83. Glossary of Terms
LIST OF FIGURES
Figure 1. Transdermal Medical Patch Market Segmentation
Figure 2. Transdermal Medical Patch Market by Region
Figure 3. Global Transdermal Medical Patch Market Overview
Figure 4. Matrix is The Largest Share of Type Segment in Transdermal Medical Patch Market
Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
Figure 6. Transdermal Medical Patch Market, by Geography (US$ Million)
Figure 7. Global Transdermal Medical Patch Market – Leading Country Markets (US$ Million)
Figure 8. North America: PEST Analysis
Figure 9. Europe: PEST Analysis
Figure 10. Asia Pacific: PEST Analysis
Figure 11. Middle East & Africa: PEST Analysis
Figure 12. South & Central America: PEST Analysis
Figure 13. Experts’ Opinion
Figure 14. Transdermal Medical Patch Market Impact Analysis of Drivers and Restraints
Figure 15. Global Transdermal Medical Patch Market – Revenue Forecast and Analysis – 2020–2028
Figure 16. Global Transdermal Medical Patch Market, by Geography – Forecast and Analysis (2022 & 2028)
Figure 17. Market Positioning of Key Players in the Transdermal Medical Patch Market
Figure 18. Transdermal Medical Patch Market Revenue Share, by Type (2022 and 2028)
Figure 19. Single-Layer Drug In-Adhesive: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Multi-Layer Drug In-Adhesive: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Reservoir: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Vapor Patch: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Matrix: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Transdermal Medical Patch Market Revenue Share, by Application (2022 and 2028)
Figure 25. Neurologic Conditions: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Pain Management: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Nicotine Cessation: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Cardiovascular Disorders: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Hormonal Therapy: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Others: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Transdermal Medical Patch Market Revenue Share, by Distribution Channels (2022 and 2028)
Figure 32. Hospital Pharmacies: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Retail Pharmacies: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Online Pharmacies: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. North America: Transdermal Medical Patch Market, by Key Country – Revenue (2022) (US$ Million)
Figure 36. North America Transdermal Medical Patch Market Revenue and Forecast to 2028 (US$ Million)
Figure 37. North America: Transdermal Medical Patch Market, by Country, 2022 & 2028 (%)
Figure 38. US: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. Canada: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. Mexico: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. Europe: Transdermal Medical Patch Market, by Key Country – Revenue (2022) (US$ Million)
Figure 42. Europe Transdermal Medical Patch Market Revenue and Forecast to 2028 (US$ Million)
Figure 43. Europe: Transdermal Medical Patch Market, by Country, 2022 & 2028 (%)
Figure 44. UK: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Germany: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. France: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 47. Spain: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 48. Italy: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 49. Rest of Europe: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 50. Asia-Pacific: Transdermal Medical Patch Market, by Key Country – Revenue (2022) (US$ Million)
Figure 51. Asia-Pacific Transdermal Medical Patch Market Revenue and Forecast to 2028 (US$ Million)
Figure 52. Asia-Pacific: Transdermal Medical Patch Market, by Country, 2022 & 2028 (%)
Figure 53. China: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 54. Japan: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 55. India: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 56. South Korea: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 57. Australia: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 58. Rest of Asia-Pacific: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 59. Middle East & Africa: Transdermal Medical Patch Market, by Key Country – Revenue (2022) (US$ Million)
Figure 60. Middle East & Africa Transdermal Medical Patch Market Revenue and Forecast to 2028 (US$ Million)
Figure 61. Middle East & Africa: Transdermal Medical Patch Market, by Country, 2022 & 2028 (%)
Figure 62. Saudi Arabia: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 63. UAE: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 64. South Africa: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 65. Rest of Middle East & Africa: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 66. South & Central America: Transdermal Medical Patch Market, by Key Country – Revenue (2022) (US$ Million)
Figure 67. South & Central America: Transdermal Medical Patch Market Revenue and Forecast to 2028 (US$ Million)
Figure 68. South & Central America: Transdermal Medical Patch Market, by Country, 2022 & 2028 (%)
Figure 69. Brazil: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 70. Argentina: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 71. Rest of South & Central America: Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)
Figure 72. Impact of COVID-19 Pandemic on North American Country Markets
Figure 73. Impact of COVID-19 Pandemic in European Country Markets
Figure 74. Impact of COVID-19 Pandemic on Asia Pacific Country Markets
Figure 75. Impact of COVID-19 Pandemic on Middle East & African Country Markets
Figure 76. Impact of COVID-19 Pandemic on South & Central America Markets
The List of Companies - Transdermal Medical Patch Market
- Hisamitsu Pharmaceutical Co Inc
- Medline Industries LP
- Johnson & Johnson
- Novartis AG
- Teva Pharmaceutical Industries Ltd
- UCB SA
- Viatris Inc
- Endo Pharmaceuticals Inc
- Boehringer Ingelheim International GmbH
- Corium, LLC
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For